Sarepta Therapeutics Inc (SRPT)
Receivables turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 1,901,979 | 1,640,348 | 1,504,993 | 1,403,300 | 1,243,336 | 1,104,982 | 1,003,434 | 975,683 | 933,013 | 876,047 | 835,184 | 765,786 | 701,887 | 645,564 | 600,082 | 573,356 | 540,099 | 495,074 | 450,191 | 407,496 |
Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $1,901,979K ÷ $—K
= —
The receivables turnover ratio for Sarepta Therapeutics Inc for the period from March 31, 2020, to December 31, 2024, is not provided in the data. Receivables turnover ratio is a financial metric that measures how efficiently a company is able to collect payments from its customers on credit sales during a specific period.
Without the specific data points for receivables turnover, we are unable to analyze the trend or assess the effectiveness of Sarepta's credit and collection policies. A higher receivables turnover ratio typically indicates a more efficient collection process and better liquidity, while a lower ratio may signal potential issues with credit control or difficulty in collecting receivables.
It is important for investors and stakeholders to monitor receivables turnover over time to understand how well the company manages its credit sales and cash flow. More consistent and timely disclosure of financial data, including receivables turnover ratio, would provide a clearer picture of Sarepta Therapeutics Inc's financial performance and operational efficiency.
Peer comparison
Dec 31, 2024